VINCOBODIES: The next generation in immunotherapy
VINCOBODIES are antibody fragments that, like antibodies, can be used in a number of therapeutic roles. At approximately one-tenth the size of a conventional antibody, VINCOBODIES penetrate tissues deeply at smaller doses for improved efficacy and safety. Vicero’s unique VINCOBODY scaffold provides the ability to simultaneously reach multiple targets with high avidity, enabling us to move rapidly into next-generation therapeutic combinations for a wide range of indications.
Evolutionary VINCOBODIES lead to revolutionary medicines
We are developing next-generation therapies for people suffering from cancers receptive to immunotherapies. The global burden of cancer is monumental, affecting the quality of life and longevity of millions of people worldwide and costing billions of dollars in direct expenses each year.
